PRTA · Prothena Corp Public Ltd Co · Webcasts, Transcripts & Audio
$8.16
-0.07 (-0.85%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Market Cap
$419.01M
Shares
51.35M
Volume · Nov 13
340.75K
Avg daily vol (3M)
464.03K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Prothena Corp Public Ltd Co Webcasts
Earnings calls, investor updates, investor days and conferences for Prothena Corp Public Ltd Co (PRTA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-09-16
Prothena Corp Public Ltd Co (PRTA) September 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Capital Markets Day
Investor event
2026-03-21
Prothena Corp Public Ltd Co (PRTA) March 21, 2026 Capital Markets Day
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-19
Prothena Corp Public Ltd Co (PRTA) Q4 2025 Earnings Call Transcript
Confident tone
PRX-12 and transferrin receptor platform
CytoPe intracellular targeting technology
Partner program milestones and economics
Revenue
$21,000*
▼ 99% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q4
2025-02-20
Prothena Corp Public Ltd Co (PRTA) Q4 2024 Earnings Call Transcript
Positive tone
PRX-12 Anti-A-beta Alzheimer's Program
Commercial Build-Out and Launch Readiness
BMS Partnership Programs
Revenue
$2.12M*
▲ 571.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q4
2024-02-15
Prothena Corp Public Ltd Co (PRTA) Q4 2023 Earnings Call Transcript
Positive tone
PRX012 in Alzheimer's disease
Birtamimab / AFFIRM-AL Phase 3 in AL Amyloidosis
Prasinezumab (Roche partnership) and PADOVA readout
Revenue
$316,000*
▼ 99.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q4
2023-02-23
Prothena Corp Public Ltd Co (PRTA) Q4 2022 Earnings Call Transcript
Revenue
$49.92M*
▲ 4159.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q4
2022-02-17
Prothena Corp Public Ltd Co (PRTA) Q4 2021 Earnings Call Transcript
Revenue
$1.17M*
▲ 225.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q4
2021-02-11
Prothena Corp Public Ltd Co (PRTA) Q4 2020 Earnings Call Transcript
Revenue
$360,000
▲ 40.6% YoY Diluted EPS
$-0.77
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Prothena Corp Public Ltd Co (PRTA) Q3 2020 Earnings Call
Revenue
$157,000
▼ 23.4% YoY Diluted EPS
$-0.77
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Prothena Corp Public Ltd Co (PRTA) Q2 2020 Earnings Call
Revenue
$195,000
▲ 16.8% YoY Diluted EPS
$-0.66
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-12
Prothena Corp Public Ltd Co (PRTA) Q4 2019 Earnings Call
Revenue
$256,000
▲ 32% YoY Diluted EPS
$-0.54
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–11 of 11 webcasts
Key facts
CIK
1559053
CUSIP
G72800108
13F (30d)
149 filings
122 filers
Visit website
Investor relations